Skip to main content

Find a clinical trial

AC-061A302

A multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium difficile associated diarrhea (CDAD) Mickael Aoun

AMC303-01

A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin Philippe Aftimos

Sevrage Tabagique

Impact of an emotion and craving regulation intervention on smoking cessation and maintenance among oncology patients : a randomised study Darius Razavi

Intervention destinée aux parents

Children facing parental cancer : a randomized controlled study evaluating the efficacy of a psychological intervention to support parenting Darius Razavi

A-48-52030-269 IMIO

An International, Multicentric, prospective, open LaBEL study to assess the efficacy and safety of Lanreotide Autogel 120 mg associated to standard of care in the treatment of clinical symptoms associated with inoperable malignant intestinal obstruction (IMIO) Dominique Lossignol

IJB_2732

A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors

I7W-MC-JQBA

A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors Ahmad Hussein Awada

A Phase 2b, Randomized, Double-blind, Single-dose, Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults who are Hospitalized with Influenza Caused by Type A Strains Mickael Aoun

MCLA-158-CL01

Phase 1 dose escalation and cohort expansion study evaluating single-agent MCLA-158 in metastatic colorectal cancer and other advanced solid tumors

EMR100036-001

A multicenter, Open-label, dose-escalating phase I trial of the DNA-PK inhibitor MSC2490484A in subjects with advanced solid tumors or chronic lymphocytic Leukemia Ahmad Hussein Awada

PanCO

An open label, single arm pilot study of OncoSilTM, administered to study participants with unresectable locally advanced pancreatic adenocarcinoma, given in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies Alain Hendlisz

OX2016-203-01

An open-label, dose-escalation, phase I study to assess the safety, pharmacokinetics and pharmacodynamics of AsiDNA, a DNA repair inhibitor administered intravenously in patients with advanced solid tumors Nuria Kotecki

IJB_2672

A Phase 3, Placebo-controlled, randomized, oserved-blindedstudy to evaluate the efficacy, safety, and tolerability of a Clostridium Difficile Vaccine in adults 50 years of age and older. Mickael Aoun

AvaWatchers

A Multicenter Non-Interventional Study exploring the impact of sarcopenia on the outcomes of colorectal cancer survivors treated with chemotherapy combined with bevacizumab Alain Hendlisz

MO29112_MODUL

A multi-centre randomized clinical trial of Biomarker-Driven maintenance treatment for first-line metastatic colorectal cancer (MODUL). Alain Hendlisz

CL1-81694-001

Phase I dose-escalation study of S 81694 administered intravenously in adult patients with advanced/metastatic solid tumours Ahmad Hussein Awada

SYD985.001

A two part first-in-human phase I study (with expanded cohorts) with the antibody-drug conjugate SYD985 to evaluate the safety, pharmacokinetics and efficacy in patients with locally advanced or metastatic solid tumors Philippe Aftimos

T2001-01

An Observational Study to Collect Data Characterizing Analgesia in Patients Suffering From Bone Metastasis Induced Pain. Dominique Lossignol

TG6002.02

A Phase I/IIa study of TG6002 (VV TK-RR-FCU1) administered by intravenous (IV) infusions in combination with oral flucytosine (5-FC) in patients with advanced gastro-intestinal (GI) tumors Christiane Jungels